Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

KABUL (Pajhwok): A laboratory has been constructed and equipped with various advanced medical instruments, diagnostic materials, tables and chairs at a cost of 35 million afghanis at the Afghan ...

Earlier this year the Therapeutic Goods Administration (TGA) halted the sale of 21 sunscreen products in Australia following ...

Delafloxacin may be more effective than current treatments at inhibiting intracellular replication of bacteria genus ...

Diego Cardeñosa always knew he wanted to study sharks. But when he started his Ph.D., he had to make a choice: tagging sharks ...

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...

In New York, cases of flu, RSV and COVID have spiked since Thanksgiving, and doctors expect that trend to continue with more ...

An analysis of CIRDC, dissecting the polymicrobial nature of the syndrome and outlining standards for diagnostic testing.

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...